| 2023-07-17 | Savara Inc. SVRA | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2022-12-21 | Sale | Arcellx, Inc. ACLX | director | 179 0.0005% | $30.74 | $5,502 | +9.86% | |
| 2022-05-03 | Sale | Robinhood Markets, Inc. HOOD | director | 1,952 0.0002% | $10.06 | $19,640 | -5.45% | |
| 2022-05-02 | Sale | Robinhood Markets, Inc. HOOD | 1,952 0.0002% | $10.06 | $19,640 | -8.78% | ||
| 2022-04-11 | Trevi Therapeutics, Inc. TRVI | 948,948 1.1133% | $1.90 | $1.8M | -15.26% | |||
| 2022-01-31 | Sale | Robinhood Markets, Inc. HOOD | director | 4,164 0.0005% | $14.22 | $59,195 | -29.75% | |
| 2021-10-18 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 3.7M 11.1305% | $0.81 | $3M | +63.35% | ||
| 2021-06-28 | Monte Rosa Therapeutics, Inc. GLUE | 10 percent owner | 1.05M 20.5778% | $19.00 | $19.95M | -7.95% | ||
| 2021-03-16 | Marker Therapeutics, Inc. MRKR | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.3% | ||
| 2020-12-04 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 4.4M 7.578% | $0.62 | $2.74M | +22.37% | ||
| 2020-07-28 | Inozyme Pharma, Inc. INZY | 10 percent owner | 250,000 1.2168% | $16.00 | $4M | +19.03% | ||
| 2020-07-14 | Nkarta, Inc. NKTX | 10 percent owner | 1.33M 2.1488% | $18.00 | $24M | -11.28% | ||
| 2020-04-13 | Sale | Mersana Therapeutics, Inc. MRSN | 10 percent owner | 41,828 0.0683% | $8.50 | $355,551 | +128% | |
| 2020-04-03 | Sale | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 1,128 0.0062% | $2.66 | $3,000 | +19.07% | |
| 2020-01-24 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 7.5M 1.0346% | $0.67 | $5M | +34.69% | ||
| 2019-07-22 | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 900,000 5.3814% | $15.00 | $13.5M | +5.09% | ||
| 2019-05-09 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 5M 34.6117% | $10.00 | $50M | -42.9% | ||
| 2019-05-07 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 1.14M 6.1239% | $1.08 | $1.23M | -40% | ||
| 2018-09-07 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 30M 4.8721% | $1.67 | $50M | -57.66% | ||
| 2018-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 12M 2.1988% | $1.92 | $23M | -12.28% |